image credit: The U.S FDA / Flickr

FDA Speeds New Guidance Development to Inform Manufacturing and Research During Pandemic

June 26, 2020

Via: PharmTech

The imperative to accelerate the development and production of new therapies and vaccines to treat patients infected by the COVID-19 virus has prompted a steady wave of new advisories from FDA on strategies for assessing new therapies and for ensuring quality products. The pandemic has required revisions in how companies maintain safe operating practices and how research sponsors assess and implement changes necessary to fit this new reality.

Read More on PharmTech